Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Tolerability of Protease Inhibitors and the Associated Impact on Persistence, Healthcare Utilization, and Healthcare Costs

NCT01450618 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT01450618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Tolerability of Protease Inhibitors and the Associated Impact on Persistence, Healthcare Utilization, and Healthcare Costs
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
October 31, 2012
Enrollment
26,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv